RecruitingNot ApplicableNCT05688293

Gingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries

Gingival Recession (RT1) Treatment With Different Gingival Augmentation Surgeries Compared With Untreated Contralateral Sites: A Randomized Controlled Clinical Study


Sponsor

Misr International University

Enrollment

30 participants

Start Date

Feb 5, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Thin gingival phenotype is one of the major causative factors of gingival recession type 1 which can result in hypersensitivity, discomfort, and compromised esthetics. This study assess the efficacy of increasing the gingival thickness from thin gingival phenotype to thick gingival phenotype in the treatment of patients suffering from gingival recession (RT1) and maintenance of results using either connective tissue graft or de-epithelized free gingival graft after non-surgical periodontal debridement compared to non-surgical periodontal debridement alone.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria4

  • Medically free patients (American Society of Anesthesiologists I; ASA I)
  • Patients diagnosed with recession (RT1)
  • Fair oral hygiene
  • Patient accepting to provides an informed consent and the follow-up

Exclusion Criteria4

  • Carious teeth and teeth with periapical infection.
  • Patients diagnosed with periodontitis
  • Smokers
  • Pregnant and lactating females

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREConnective tissue graft

non-surgical periodontal treatment and connective tissue graft

PROCEDUREFree gingival graft

will receive non-surgical periodontal treatment and partially de-epithelized free gingival graft

PROCEDURENon surgical

non-surgical periodontal treatment only


Locations(1)

Faculty of oral and dental medicine, Misr international university

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05688293


Related Trials